© infomatique

Trinity College Dublin's Center for Research on Adaptive Nanostructures and Nanodevices (CRANN) has been awarded €15.5 million in funding to lead two European nano research projects.

CRANN, along with Trinity College Dublin's Institute of Molecular Medicine and its School of Medicine as well as Cellix Ltd. and Radisens Diagnostics, will lead a team developing new nanomedicine solutions for early diagnosis of cancer.

"This is a huge vote of confidence and recognizes Irish leadership in the cutting edge field of nanomedicine," says Professor Dermot Kelleher, head of the Trinity College Dublin School of Medicine and director of the Institute of Molecular Medicine.

"This research program will address some of the most important questions in human medicine relating to diagnosis and treatment of cancer, using 21st century experience and know-how in nanotechnology — and we are looking forward to the time when our patients here will benefit from these innovative technologies," Kelleher says.

The press release is here.

• Studying to be a Nanotechnology Expert
• Rice University awarded $3 million for breast cancer research
• Novellus Announces $20 Million Partnership with CNSE
• St. Louis Institute of Nanomedicine Working Group Formed